TransMedics Group Inc (NAS:TMDX)
$ 145.96 2.885 (2.02%) Market Cap: 4.81 Bil Enterprise Value: 4.97 Bil PE Ratio: 0 PB Ratio: 30.07 GF Score: 80/100

Transmedics Group Inc Annual Shareholders Meeting Transcript

Jun 04, 2020 / 12:00PM GMT
Release Date Price: $14.2 (+0.85%)
Operator

Good morning, ladies and gentlemen, and welcome to the TransMedics Group Annual Shareholder Meeting.

At this time, the meeting will begin, and it is my pleasure to turn the floor over to your host, Waleed Hassanein. Sir, the floor is yours.

Waleed H. Hassanein;James R. Tobin
TransMedics Group, Inc. - Founder, CEO, President & Director;TransMedics Group, Inc. - Independent Chairman

Thank you so much. Good morning, everyone, and welcome to the 2020 Annual Meeting of Shareholders of TransMedics Group. I'm Waleed Hassanein, President and CEO of the TransMedics Group.

Leveraging our Organ Care System technology, TransMedics is well underway to transform the global field of organ transplantation for lung, heart and liver failure patients. We are grateful for your shareholder support for our company. This year, in light of the COVID-19 pandemic, we have decided to host our annual meeting virtually.

It is my distinct pleasure to welcome you and to introduce Jim Tobin, our Chairman of the Board. Jim?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot